These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31749804)

  • 1.
    Gröbner R; Kapferer-Seebacher I; Amberger A; Redolfi R; Dalonneau F; Björck E; Milnes D; Bally I; Rossi V; Thielens N; Stoiber H; Gaboriaud C; Zschocke J
    Front Immunol; 2019; 10():2537. PubMed ID: 31749804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Different Missense
    Bally I; Dalonneau F; Chouquet A; Gröbner R; Amberger A; Kapferer-Seebacher I; Stoiber H; Zschocke J; Thielens NM; Rossi V; Gaboriaud C
    Front Immunol; 2019; 10():2962. PubMed ID: 31921203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of collagen I by activated C1s in periodontal Ehlers-Danlos Syndrome.
    Amberger A; Pertoll J; Traunfellner P; Kapferer-Seebacher I; Stoiber H; Klimaschewski L; Thielens N; Gaboriaud C; Zschocke J
    Front Immunol; 2023; 14():1157421. PubMed ID: 36960056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement.
    Kapferer-Seebacher I; Pepin M; Werner R; Aitman TJ; Nordgren A; Stoiber H; Thielens N; Gaboriaud C; Amberger A; Schossig A; Gruber R; Giunta C; Bamshad M; Björck E; Chen C; Chitayat D; Dorschner M; Schmitt-Egenolf M; Hale CJ; Hanna D; Hennies HC; Heiss-Kisielewsky I; Lindstrand A; Lundberg P; Mitchell AL; Nickerson DA; Reinstein E; Rohrbach M; Romani N; Schmuth M; Silver R; Taylan F; Vandersteen A; Vandrovcova J; Weerakkody R; Yang M; Pope FM; ; Byers PH; Zschocke J
    Am J Hum Genet; 2016 Nov; 99(5):1005-1014. PubMed ID: 27745832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A familial case of periodontal Ehlers-Danlos syndrome lacking skin extensibility and joint hypermobility with a missense mutation in C1R.
    Nakajima K; Suzuki H; Yamamoto M; Yamamoto T; Kawai T; Nakabayashi K; Hata K; Kosaki K; Nakajima H; Sano S; Kubo A
    J Dermatol; 2022 Jul; 49(7):714-718. PubMed ID: 35365885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal (formerly type VIII) Ehlers-Danlos syndrome: Description of 13 novel cases and expansion of the clinical phenotype.
    El Chehadeh S; Legrand A; Stoetzel C; Geoffroy V; Billon C; Adham S; Jeunemaître X; Jaussaud R; Muller J; Schaefer E; Benistan K; Gaertner S; Bloch-Zupan A; Courval A; Manière MC; Petit C; Bursztejn AC; Bal L; Reyre A; Chammas A; Busa T; Dollfus H; Lipsker D
    Clin Genet; 2021 Aug; 100(2):206-212. PubMed ID: 33890303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
    J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontal manifestations of Ehlers-Danlos syndromes: A systematic review.
    Kapferer-Seebacher I; Lundberg P; Malfait F; Zschocke J
    J Clin Periodontol; 2017 Nov; 44(11):1088-1100. PubMed ID: 28836281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites.
    Bally I; Ancelet S; Moriscot C; Gonnet F; Mantovani A; Daniel R; Schoehn G; Arlaud GJ; Thielens NM
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8650-5. PubMed ID: 23650384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 activation and dissociation in disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis.
    Radanova M; Vasilev V; Mihaylova G; Kosturkova M; Kishore U; Roumenina L
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome.
    Angwin C; Zschocke J; Kammin T; Björck E; Bowen J; Brady AF; Burns H; Cummings C; Gardner R; Ghali N; Gröbner R; Harris J; Higgins M; Johnson D; Lepperdinger U; Milnes D; Pope FM; Sehra R; Kapferer-Seebacher I; Sobey G; Van Dijk FS
    Front Genet; 2023; 14():1136339. PubMed ID: 37323685
    [No Abstract]   [Full Text] [Related]  

  • 14. Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex.
    Brier S; Pflieger D; Le Mignon M; Bally I; Gaboriaud C; Arlaud GJ; Daniel R
    J Biol Chem; 2010 Oct; 285(42):32251-63. PubMed ID: 20592021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective clinical investigations of children with periodontal Ehlers-Danlos syndrome identify generalized lack of attached gingiva as a pathognomonic feature.
    Kapferer-Seebacher I; Oakley-Hannibal E; Lepperdinger U; Johnson D; Ghali N; Brady AF; Sobey G; Zschocke J; van Dijk FS
    Genet Med; 2021 Feb; 23(2):316-322. PubMed ID: 33005042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal Ehlers-Danlos syndrome is associated with leukoencephalopathy.
    Kapferer-Seebacher I; Waisfisz Q; Boesch S; Bronk M; van Tintelen P; Gizewski ER; Groebner R; Zschocke J; van der Knaap MS
    Neurogenetics; 2019 Mar; 20(1):1-8. PubMed ID: 30535813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement.
    Bally I; Rossi V; Lunardi T; Thielens NM; Gaboriaud C; Arlaud GJ
    J Biol Chem; 2009 Jul; 284(29):19340-8. PubMed ID: 19473974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical complement pathway components C1r and C1s: purification from human serum and in recombinant form and functional characterization.
    Rossi V; Bally I; Lacroix M; Arlaud GJ; Thielens NM
    Methods Mol Biol; 2014; 1100():43-60. PubMed ID: 24218249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.